Skip to main content
. Author manuscript; available in PMC: 2015 Apr 8.
Published in final edited form as: J Clin Psychopharmacol. 2011 Apr;31(2):154–159. doi: 10.1097/JCP.0b013e31820fcea3

TABLE 1.

Baseline Patient Characteristics (n = 30)

Mean (SD) age, y 27.5 (7.0)
Sex, % male 66.7
Race, % white 90
% Residing in catchment area 83
Mean (SD) no. cigarettes/d 8.1 (9.7)
Mean (SD) SES 4.9 (1.6)
Mean (SD) PANSS positive 25 (7)
Mean (SD) PANSS negative 23 (9)
Mean (SD) PANSS general 39 (10)
Mean (SD) PANSS total 87 (20)
Mean (SD) duration of untreated psychosis, mo 1.5 (1.4)
Mean (SD) BMI 22.1 (3.0)
Mean (SD) total cholesterol, mg/dL 163 (30)
Mean (SD) triglycerides, mg/dL 80 (26)
Mean (SD) LDL, mg/dL 97 (27)
Mean (SD) HDL, mg/dL 50 (14)
Mean (SD) fasting glucose, mg/dL 82 (8)
Mean (SD) HbA1c (%) 4.4 (0.3)
Mean (SD) 2-h glucose, mg/dL 110 (35)
Mean (SD) fasting insulin, mg/dL 9.7 (4.4)
Mean (SD) leptin, mg/dL 7.3 (10.4)
Mean (SD) adiponectin, mg/dL 12.3 (5.9)
Mean (SD) C-reactive peptide, mg/dL 0.21 (0.34)
Mean (SD) IL-6, pg/mL 3.5 (7.2)
Mean (SD) cortisol, mg/dL 18.3 (5.6)
Parental history of DM2, % yes 23.3

PANSS indicates Positive and Negative Syndromes Scale.